By Matt Jones

NEW YORK (GenomeWeb News) – The annual ritual that National Institutes of Health directors make of heading to Capitol Hill to justify their fiscal budgets and to make the case for supporting biomedical research could become easier — if a new initiative to monitor federal investments in science achieves its goals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.